Fumiaki Nonaka, Shoichi Fukui, Tohru Michitsuji, Yushiro Endo, Ayako Nishino, Toshimasa Shimizu, Masataka Umeda, Remi Sumiyoshi, Tomohiro Koga, Naoki Iwamoto, Tomoki Origuchi, Yukitaka Ueki, Nobutaka Eiraku, Takahisa Suzuki, Akitomo Okada, Naoki Matsuoka, Hirokazu Takaoka, Hiroaki Hamada, Tomomi Tsuru, Yojiro Arinobu, Toshihiko Hidaka, Keita Fujikawa, Tamami Yoshitama, Yoshifumi Tada, Hideo Ohtsubo, Jun Ishizaki, Tomoyuki Asano, Takahiro Maeda, Atsushi Kawakami, Shin-Ya Kawashiri
OBJECTIVE: Glucocorticoids are effective in treating rheumatoid arthritis (RA) when used appropriately considering the balance of the risks and benefits, especially at low doses. We aimed to evaluate the response of biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in patients having already been treated with glucocorticoids. METHODS: We reviewed RA patients treated with b/tsDMARDs in a prospective multicenter ultrasound cohort study...
March 2024: International Journal of Rheumatic Diseases